about
Assessment of blood flow with (68)Ga-DOTA PET in experimental inflammation: a validation study using (15)O-water.Accumulation of piRNAs in the chromatoid bodies purified by a novel isolation protocol.Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.Absorption, distribution and excretion of intravenously injected (68)Ge/ (68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitisA Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate.Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholineLeukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.In vivo imaging of Lyme arthritis in mice by [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.(18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography.Erratum to: Absorption, distribution and excretion of intravenously injected (68)Ge/(68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry.Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation.Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism.Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [68Ga]Ga- and [18F]AlF-NOTA-Siglec-9.Cross-validation of input functions obtained by H₂ 15O PET imaging of rat heart and a blood flow-through detector.Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry.Evaluation of (68)Ga-labeled peptide tracer for detection of gelatinase expression after myocardial infarction in rat.Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice.18-kDa translocator protein ligand 18F-FEMPA: Biodistribution and uptake into atherosclerotic plaques in mice.In Vivo Bone-Targeting of Bis(phosphonate)-Conjugated Double Helical RNA Monitored by Positron Emission Tomography.Synthesis and In Vivo PET Imaging of Hyaluronan Conjugates of Oligonucleotides.Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.Solid-supported NOTA and DOTA chelators useful for the synthesis of 3'-radiometalated oligonucleotides.Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with 18F-GE-180, a Radiotracer for Translocator Protein (TSPO).Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography.Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [ 18 F]FDG uptake in Ldlr −/− Apob 100/100 miceDimeric [68Ga]DOTA-RGD Peptide Targeting αvβ3 Integrin Reveals Extracellular Matrix Alterations after Myocardial InfarctionPharmacological Activation of the Melanocortin System Limits Plaque Inflammation and Ameliorates Vascular Dysfunction in Atherosclerotic MiceSynthesis of multi-galactose-conjugated 2′-O-methyl oligoribonucleotides and their in vivo imaging with positron emission tomographyAmyloid-Targeting PET Tracer [F]Flutemetamol Accumulates in Atherosclerotic Plaques
P50
Q30854806-4B873612-F7D5-4F4C-A431-8AE5B923B58DQ33539482-934E26CE-45F4-439D-B89F-563C56888157Q33817609-26FCF8D7-65B7-4B38-BA8A-9BE59379CF0AQ35858931-EA20EDD6-C4D3-43AA-9A59-D25EE331618FQ36246891-0E8547B4-BF2E-4C61-A43A-85D69C534F03Q36262416-6B0EE33F-BD75-4090-BE65-8F16DB257329Q36553346-E997419F-B841-4619-AA24-BB7066D43F29Q37330522-3A95F458-5C28-40BE-A662-5981626E4902Q38709331-89DCE48C-E579-4D23-B4E0-1005B564056FQ38981899-2226FDC0-0EE1-4142-9C4A-FE7D7766B608Q41064055-CB5124CE-6498-400F-A86F-8A45C8C34EF8Q42725847-7274F7B8-B6E3-406F-BA5D-FC6E7140BA32Q43756878-7F699682-EC20-4346-9DA1-CF64626ABE8CQ46733619-05ED154E-9053-4D3B-B068-001C68BE9244Q47372972-6D453053-DF25-4400-9135-1056E06088CCQ48133997-CC458D84-8EE2-4087-8C86-D03A24A61B26Q48967192-73F6527C-7035-455A-82E1-F613D51667C6Q49788469-FB5AE40E-9405-4049-97D9-2488EAE51B73Q51030206-031F6C03-0231-4D59-9C53-928934597C04Q51302893-3B649ECF-8539-4815-BC7F-7E8F1C3C07A0Q52851885-AE229DDA-4220-4B8D-B9C3-BD95D0890EB5Q52982769-CFCFF8C3-5805-413D-983F-33E7515CE50FQ52989546-4065D79A-2DA4-4ECA-80CB-778A820D3B0DQ52999991-73D2015F-7358-4C6A-959C-5C406BE20B6BQ53152710-1E55C041-A673-422B-890B-CB53353B1B03Q55291485-EA7C1D51-EC04-4666-A71D-59E83C8BE6C9Q55399614-00262081-C3EC-40F4-BD8D-11283577E143Q55438478-07616C79-C713-4BAA-95A1-008948DAF754Q57621268-1EA5AAA9-246A-4DCA-962E-4A43BBD2CE53Q57621665-A85CC1C9-5C0B-4BDD-A3EB-7F9EB3C1F13AQ57621778-14708BE7-3AB4-4BE9-B7E6-A5BE2C5A9B34Q60375060-1BE0B13B-7A8C-44B9-A03E-6FFE0F79D943Q64077091-422726DC-7EBE-4FAE-91B0-4956ADA44EF9
P50
description
researcher ORCID ID = 0000-0001-9372-1584
@en
wetenschapper
@nl
name
Heidi Liljenbäck
@ast
Heidi Liljenbäck
@en
Heidi Liljenbäck
@nl
type
label
Heidi Liljenbäck
@ast
Heidi Liljenbäck
@en
Heidi Liljenbäck
@nl
prefLabel
Heidi Liljenbäck
@ast
Heidi Liljenbäck
@en
Heidi Liljenbäck
@nl
P31
P496
0000-0001-9372-1584